Status:
UNKNOWN
Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH
Lead Sponsor:
Yazd Research & Clinical Center for Infertility
Conditions:
Infertility
Eligibility:
FEMALE
Up to 35 years
Phase:
PHASE3
Brief Summary
Literature suggests that GnRH antagonists are comparatively more often used in cycles which have an unfavorable prior prognosis, and this protocol is an ideal one for poor responder patients. Up to no...
Eligibility Criteria
Inclusion
- first cycle of ART
- age \< 35 years
- basal FSH \< 10 IU/L
Exclusion
- previous IVF or ICSI, hyperprolactinemia, hyperthyroidism, hypothyroidism, uterine abnormality, severe endometriosis
- only one ovary
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2009
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00823602
Start Date
March 1 2008
End Date
January 1 2009
Last Update
January 15 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yazd Research and Clinical Center For Infertility
Yazd, Yazd Province, Iran